CEO says Hormel Foods is well-positioned as weight-loss drugs grow popular
Hormel Foods CEO Jim Snee told CNBC's Jim Cramer on Thursday that his company is set up to do well as weight-loss drugs gain popularity, citing a varied "protein portfolio." "No matter how you think about our portfolio, you're going to encounter protein, which is a really important part of any…#hormelfoods #jimsnee #jimcramer #skippy #justin #snee #planters (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2024 Category: Consumer Health News Source Type: news

‘Epidemic of obesity’ blights children as global rates soar
Research shows urgent need for policies to encourage weight loss and cut disease risk (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 29, 2024 Category: Pharmaceuticals Source Type: news

5 Investors Betting Big on Weight Watchers (WW) Stock as Oprah Backs Out
Institutional investors increased their WW stock exposure by 5.16% during Q4 Shares of WW International (NASDAQ:WW) stock are plunging lower after the weight loss and fitness company reported its fourth-quarter earnings. WW also revealed that Oprah Winfrey has decided not to seek re-election as…#ww #wwinternational #oprahwinfrey #winfreyfirst #winfrey #yoy #novonordisk #nvo #elililly #lly (Source: Reuters: Health)
Source: Reuters: Health - February 29, 2024 Category: Consumer Health News Source Type: news

FDA chief sounds alarm over sale of fake weight loss drugs circulating online
GLP-1 agonist drugs are having their moment in the spotlight, but shortages brought on by increased demand are compelling some users to look for quick alternatives that have U.S. Food and Drug Administration (FDA) Commissioner Dr. Robert Califf a bit concerned. Compounded versions of the drugs –…#glp1 #fda #robertcaliff #novonordiskozempic # #wegovy #novonordisk #elililly #mounjaro #gip (Source: Reuters: Health)
Source: Reuters: Health - February 29, 2024 Category: Consumer Health News Source Type: news

Viking Therapeutics stock has wild week after weight-loss drug results impress Wall Street
Viking Therapeutics stock (VKTX) has been on a tear this week after it announced the phase II clinical trial results for a new experimental drug in the booming weight-loss industry. On Tuesday, shares of Viking Therapeutics more than doubled, soaring over 120% to $85 as Wall Street cheered the…#vikingtherapeutics #novonordisk #wegovy #elililly #lly #justinzelin #yahoofinancelive #lilly #williamblair #glp (Source: Reuters: Health)
Source: Reuters: Health - February 29, 2024 Category: Consumer Health News Source Type: news

New weight-loss drug being reviewed by FDA burns fat FIVE TIMES quicker than Ozempic and Wegovy
The California-based start-up behind the drug has seen its share price double after the results were revealed, for its once-a-week injection called VK2735. (Source: the Mail online | Health)
Source: the Mail online | Health - February 29, 2024 Category: Consumer Health News Source Type: news

Biden's Physical Results; Weight Loss Implant Tested; Richard Lewis Dies
(MedPage Today) -- Note that some links may require registration or subscription. President Joe Biden "continues to be fit for duty," his doctor said after Biden's annual physical during election year. (AP) Layoffs and corporate restructuring... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - February 29, 2024 Category: Endocrinology Source Type: news

Multimodal Pre-Op Program Aids Knee Replacement Candidates
(MedPage Today) -- Having patients waiting for knee arthroplasty undergo a preoperative program of weight loss, exercise, and other interventions gave them modestly improved pain, function, and quality of life, a small randomized trial showed... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 29, 2024 Category: Primary Care Source Type: news

Sustained weight management effective in controlling type 2 diabetes
Weight loss can put type 2 diabetes into remission for at least five years, new research suggests. Scientists at the University of Newcastle showed that long-term remission from type 2 diabetes is possible if sufficient weight loss is achieved and maintained. The five-year study found that over a quarter of the participants in remission at... Read moreThe post Sustained weight management effective in controlling type 2 diabetes appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - February 29, 2024 Category: Nursing Authors: Carolyn Scott Tags: Diabetes weight loss Source Type: news

Oprah will leave the Weight Watchers board and donate the proceeds from her stake in the company ‘to eliminate any perceived conflict of interest around her…
Oprah Winfrey is standing down from the board of WW International, also known as WeightWatchers, and the reason why has to do with her use of weight loss medication—probably. Winfrey joined the company in 2015 after buying a $43 million stake in the weight loss and fitness company, joining the…#oprahwinfrey #wwinternational #weightwatchers #ww #sequence #glp1 #winfrey #strategicterm #winfreya (Source: Reuters: Health)
Source: Reuters: Health - February 29, 2024 Category: Consumer Health News Source Type: news

Ozempic, Oprah, And Weight Loss Culture
“I’m not quite sure that something’s that’s just a tiny little prick can be so powerful in so many ways.” I’m not 14, but every time I hear that line, I giggle. It’s said in earnest as part of a woman’s testimonial for Ro.co, a telehealth enterprise now busy selling an Ozempic-like drug, one in a…#glp1s #clevelandclinic #gray #magnum #roman #viagra #novonordisk #danish #ozempicandwagovy #denmark (Source: Reuters: Health)
Source: Reuters: Health - February 29, 2024 Category: Consumer Health News Source Type: news

Weight-loss drug may be launched in India next year, says Eli Lilly CEO David Ricks
US drug maker Eli Lilly plans to launch its weight-loss drugs Zepbound and Mounjaro in India next year. The company is considering pricing based on supply and volume expansion. Eli Lilly CEO David Ricks suggests focusing on digital services in the Indian healthcare industry to encourage innovation and improve access to healthcare. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 29, 2024 Category: Pharmaceuticals Source Type: news

The life-threatening dangers of the 'budget Ozempic' TikTokers are turning to because the weight-loss drug is too expensive
Ozempic is all the craze for weight loss in the US. But with its hefty price tag, many are turning to alternatives - such as 'budget Ozempic' laxatives. Doctors warn against this. (Source: the Mail online | Health)
Source: the Mail online | Health - February 28, 2024 Category: Consumer Health News Source Type: news

Why Is Vivani Medical (VANI) Stock Up 300% Today?
Little-known emerging biopharmaceutical company Vivani Medical (NASDAQ:VANI) saw its market value increase dramatically on Wednesday. Catapulting sentiment was the company’s weight-loss solution, which offered compelling results compared to mainline weight-loss therapeutics. Given Vivani’s…#vivanimedical #obese #ozempic #novonordisk #nvo #ozempicandwegovy #fda #wegovy #perjohnshopkins #maximgroups (Source: Reuters: Health)
Source: Reuters: Health - February 28, 2024 Category: Consumer Health News Source Type: news

US FDA Chief Very Concerned About Fake Weight Loss Drugs US FDA Chief Very Concerned About Fake Weight Loss Drugs
U.S. Food and Drug Administration Commissioner Dr. Robert Califf said on Wednesday that he is very concerned about the prevalence of compounded and fake versions of highly...Reuters Health Information (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - February 28, 2024 Category: Primary Care Tags: Diabetes & Endocrinology Source Type: news